The opportunity for the nutricosmetic space is huge, but benefits should be well researched and communicated so that consumers get what they pay for.

Consumers want clean-label products that really work

Can they take on the market’s old guard?

Immune health: New, novel ingredients are on the scene

FoodTech startup Imaginedary Ltd. (Tel Aviv, Israel), which is a developer of animal-free milk proteins, has raised an additional $15 million in its extended seed-round on top of the $13 million it had originally brought in November of 2021. With a total investment capital of $28 million makes this one of the highest-earning seed rounds in the alternative protein space, according to Imaginedairy.

The funding was led by Target Global and joined by the company’s existing investors Strauss Group, Emerald Technology Ventures, Green Circle Foodtech Ventures, Collaborative Fund, New Climate Ventures, and FoodSparks by PeakBridge. Imaginedairy creates animal-free proteins from microorganisms using proprietary precision fermentation technology, allowing the company to produce a wide spectrum of dairy analogs, from raw milk to cheese, without the use of animals. These dairy proteins are non-GMO, cholesterol-free and possess the same flavor, texture, functionality, and nutritional value of its animal dairy counterparts.

The company’s proprietary platform significantly amplifies protein expression, allowing for very cost-effective production of animal-free milk proteins. Cost is one of the biggest hurdles in alt-dairy protein production.

“This extremely successful seed round reflects a strong vote of confidence in Imagindairy and its vision to lead the animal-free dairy industry,” enthused Eyal Afergan, co-founder and CEO of Imagindairy, in a press release. “This substantial injection of capital will serve to advance our ability to make true dairy alternative products a day-to-day reality.”

The funds raised in this seed round will be used to accelerate research and development efforts to launch a range of animal-free dairy products, as well as to help attract additional talent to its expanding workforce.

“We are excited to be able to back the Imagindairy team who have made incredible inroads in creating dairy products that don't rely on industrialized animal agriculture but offer the same level of functionality and nutrition,” said Shmuel Chafets, executive chairman and founder at Target Global. “It is becoming increasingly clear that, given the climate crisis and growing shortage of food, our dietary patterns and habits must change. Animal-free dairy has the potential to become one of the most environmentally impactful industries on the planet. We are strong believers that the Imagindairy team’s vast experience in manufacturing at scale, paired with the cutting-edge technology they have built, will be transformational for this space." Target Global’s contribution to this round marks one of its first investments in the foodTech industry.

Articles

FoodTech startup Imaginedary Ltd., which is a developer of animal-free milk proteins, has raised an additional $15 million in its extended seed-round on top of the $13 million it had originally brought in November of 2021.

Animal-free dairy startup Imagindairy secures additional funding 

 conducted by Validcare demonstrates the strong safety profile of orally-ingested CBD. This study builds on the results of a 

 that included a cohort of 839 subjects taking CBD products manufactured by 12 companies. That cohort used liver function as a primary endpoint, and determined that supplementation with CBD did not negatively impact liver function. With the addition of the second cohort, researchers added 222 subjects taking CBD products manufactured by five companies, and tested CBD’s impact on testosterone levels and daytime drowsiness, in addition to live function. Combined, the study included 1,061 participants and used products from 17 different CBD companies.

The combined results of the first and second cohorts strengthened the statistical reliability of CBD’s safety profile with regard to liver function and demonstrated positive effects on testosterone levels and daytime drowsiness. Results also showed that CBD consumption had a significant positive association between testosterone levels and dose of CBD per weight, and lower Standard Sleep Scale values, meaning that CBD consumption was actually associated with improved daytime alertness and less drowsiness.

“The data in this study looks really good; it’s highly significant, and the chances of it being wrong are very, very small,” stated Robert Kaufmann, MD, director of research for Validcare and former Professor of Medicine at Southern Illinois University School of Medicine, in a press release. “I am very hopeful that this data will allow the FDA to regulate these popular CBD products.”

“We are excited to report that the ‘real-world data’ that FDA has been soliciting addresses the agency’s safety concerns,” stated Jonathan Miller, General Counsel to the U.S. Hemp Roundtable, the hemp industry’s national advocacy organization. “The time has come for FDA to regulate CBD and other hemp derivatives. If FDA does not act, we call on Congress to pass legislation such as HR 841, HR 6134 and S. 1698 which would require the FDA to develop regulatory pathways for the sale of hemp extracts like CBD in ingestible form.”

“This study reaffirms the safety of Charlotte’s Web hemp-derived CBD extracts and are proof of the hemp CBD industry working cooperatively to support rigorous scientific research to inform regulators, the FDA, and the U.S. Congress,” offered Charlotte’s Web senior vice president and the Company’s president of its CW Labs Division Tim Orr. “With 1,060 participants in two cohort studies, industry stepped up and delivered the requested science for hemp CBD, again, by providing evidence outcomes in liver safety, drowsiness, testosterone impact and diabetes prevalence.”

Charlotte’s Web was one of the companies that provided funding and products to use in the study. The other participating companies include: Asterra Labs, Cannacraft, CBDistillery, CBD American Shaman, Columbia Care, Garden of Life, Global Widget, HempFusion, Impact Naturals, Kannaway, Kazmira, Medterra CBD, SunMed CBD, and Tauriga Sciences.

A new safety study conducted by Validcare demonstrates the strong safety profile of orally-ingested CBD. This study builds on the results of a previous safety study that included a cohort of 839 subjects taking CBD products manufactured by 12 companies. 

New study demonstrates safety profile of CBD on multiple endpoints, including liver function, testosterone levels, and daytime drowsiness

The US. Senate Committee on Health, Education, Labor, and Pensions (HELP) has released a 

 of the FDA Safety and Landmark Advancements (FDASLA) Act, which is legislation that would reauthorize FDA’s prescription drug, generic drug, biosimilar, and medical device user fee agreements. Included in the legislation is also a 

 for dietary supplements that was recently introduced by Senate Majority Whip Dick Durbin (D-IL), and co-sponsored by Senator Mike Braun (R-IN). The proposal has sparked some controversy within the dietary supplement industry, with some stakeholders fiercely opposing the proposed legislation, calling it pre-market approval, while others are advocating for its passage.

“The NPA is significantly concerned with Chair Murray and Republican Leader Burr who failed to reject the radical and dangerous legislation from Senators Durbin and Braun that would require premarket approval for dietary supplements and weaken key privacy protections of the Bioterrorism Act, which protects the dietary supplement supply chain,” said Daniel Fabricant, PhD, president and CEO of the Natural Products Association (NPA; Washington, D.C.), in a press release. “Last time I checked, dietary supplements are not drugs, biologics, or medical devices, so why is Congress or anyone supporting nongermane legislation that will only add costs to consumers who are doing all they can to stay healthy is extremely troubling. Groups who have supported this legislation, have stated there are protections for technical disagreements with the FDA like those with hemp, CBD, NAC, and several other products. However, if this legislation were to pass, it is abundantly clear these products would be eliminated from the market.”

Earlier this month, the House Committee on Energy & Commerce unveiled its own 

 which did not include a mandatory product listing requirement. NPA continues its 

 to prevent the Durbin-Braun proposal from coming to fruition.

The US. Senate Committee on Health, Education, Labor, and Pensions (HELP) has released a discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act, which is legislation that would reauthorize FDA’s prescription drug, generic drug, biosimilar, and medical device user fee agreements.

New legislation from U.S. Senate for FDA user fee reauthorization includes mandatory product listing requirement

Jennifer Grebow is the editor-in-chief of 

, an award-winning media-content provider in the dietary supplement and natural products market. 

, an MJH Life Sciences brand, provides insights and industry updates critical to manufacturers of dietary supplements, healthy foods, and nutritious beverages. 

 keeps industry abreast of current market trends, research updates, news, and regulatory developments. 

goes beyond the 24-hour news cycle and provides in-depth analysis to help industry players navigate the challenges and changes in the near- and long-term. 

, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

Lonza (Basel, Switzerland) has added a titanium dioxide–free (TiO

 free) white hard gelatin capsule to its Capsugel capsules line to help companies meet new European Union regulations banning titanium dioxide from foods. The European Commission is now 

 as a food additive in the EU, with a six-month phaseout period that ends August 7, 2022.

Lonza already offers other titanium dioxide–free capsules, such as its Capsugel White Opal HPMC capsule. The newest hard gelatin capsule provides a bright white color and features alternative opacifying technology. It also offers good masking and protection of the product formula from light, the company says.

As the company’s press release explains, “This novel opacifying technology leverages the functionality of crystalized salts to provide the same whiteness and masking as capsules containing TiO

. In an internal head-to-head comparison study, Lonza’s TiO

 alternative solution provided excellent light protection and opacity compared to other TiO

 alternatives as well as capsules produced with TiO

The European Commission is now banning titanium dioxide as a food additive in the EU, with a six-month phaseout period that ends August 7, 2022. 

New titanium dioxide–free white hard gelatin capsules from Lonza meet EU requirements banning TiO2

IFF (New York City) has introduced new bioprotective cultures that help ensure dairy and dairy-alternative products still look and taste fresh so that consumers don’t wastefully discard food they can still eat. Brand-named Holdbac, the two new protective cultures use “specially selected microorganisms that deliver long-lasting freshness” while still maintaining label friendliness and avoiding artificial preservatives.

As the company’s press release explains, many food manufacturers are switching from labeling their products with “use by” dates and instead opting for “best before” dates—and letting consumers judge whether a product is still edible. The goal is to eliminate unnecessary food waste.

“The whole idea behind ‘best before’ dates is to encourage consumers to trust their own senses more when deciding if a food product is still good enough to eat,” said Julien Plault, global protective cultures manager at IFF, in a press release. “We know, for example, that 17% of all yogurts in the European Union (EU) have previously been thrown away simply because they had passed their ‘use by’ date. This needs to be changed, and our solutions can play a role.”

He added: “Bioprotective cultures contribute in maintaining the quality of fresh dairy products is intact at the end of their formal shelf life, so they still look, taste, and feel fresh. If ‘best before’ is to have any impact on preventing avoidable food waste, this is absolutely key.”

The cultures do not compromise a product’s sensory experience, ensuring “fresh dairy products have the same delicious taste and texture at the end of shelf life as at the beginning.” It even maintains these in challenging storage temperatures, the company says.

Plault added, “Both cultures are easy to combine with the starter culture at the beginning of fresh dairy processes. The idea is to release the full power of fermentation. That makes it possible to overcome recipe and food waste challenges while maintaining the integrity of the brand.”

Brand-named Holdbac, the two new protective cultures use “specially selected microorganisms that deliver long-lasting freshness” while still maintaining label friendliness and avoiding artificial preservatives.

IFF’s new cultures keep dairy and alternative-dairy products fresh, encouraging consumers not to discard food that’s still edible

Taste and nutrition ingredients company Kerry has opened an ingredient manufacturing facility in Hammarsdale, KwaZulu-Natal, in South Africa, which it says “will produce sustainable nutrition solutions that will be consumed across the African continent.”

 facility “the largest and most advanced taste manufacturing facility on the African continent.” The facility is one of the company’s most environmentally efficient manufacturing sites, it says, featuring everything from low-energy-usage equipment and solar power generation to waste heat capture and efficient water capture, reuse, and reduction.

Speaking at the facility’s opening on May 9, Nomalungelo Gina, South Africa’s deputy minister of trade, industry, and competition, said, “The project is recognized as a key strategic investment in the region of Kwa-Zulu Natal and within South Africa’s food manufacturing industry and has been included as part of the South African Presidential investment drive to stimulate sustainable, equitable, and inclusive growth as the foundation for socioeconomic transformation in the country. We are excited about this investment because it aligns very well with our reimagined industrial strategy.”

Paul Hewitt, vice president, Sub-Saharan Africa, Kerry Group, said, “South Africa is in a unique position to service East, Central, as well as West Africa, and we look forward to working with food and beverage companies to create products that will be enjoyed across the continent.”

Kerry calls the new facility the “largest and most advanced taste facility in Africa.”

Kerry opens South African nutrition and taste ingredient manufacturing facility

Photo © Svetlana Lukienko - Stock.adobe.com

Increasingly, a stronger association is being drawn between beauty and one’s health. When it comes to body care, consumers are becoming more wary about what they put on their bodies and therefore associate healthy body care with natural, clean-label, and organic positioning. According to market research firm SPINS (Chicago), body care products positioned as natural saw 14% sales growth, compared to a little over 1% growth for conventional-positioned body care products, in both the natural and multioutlet retail channels during the 52 weeks ending January 24, 2021. Across all channels, cosmetics labeled “vegan” grew in sales by 34%, and those labeled “organic” grew 52%. In addition to this, well-informed consumers are actively avoiding certain ingredients like triclosan, talc, oxybenzone, and octinoxate.

Beyond the positioning and composition of body care products, consumers are also beginning to see the value of body care products as an extension of their overall wellbeing. For example, topical skincare products that utilize calming ingredients such as chamomile connect with consumers’ desire to reduce stress in their lives. Functional ingredients associated with wellness make body care products more appealing to consumers. According to SPINS, sales of body care products with probiotics have seen 22% sales growth, for instance, and products with turmeric have experienced 41% sales growth.

Beauty companies are tapping into consumers’ growing acceptance that different aspects of our health are interconnected. And while consumers understand that what they put on their body may affect what happens inside their body, they also understand that what they put in their body also affects what happens on the surface.

“Beauty from within is no longer a niche or micro-trend but is now encompassed by many via dietary, functional foods/beverages, and natural health products to suit almost any lifestyle and product preference,” says Paula Simpson, nutricosmetics innovation and formulation expert, founder of Nutribloom, and author of 

 “Today, people are looking for integrative ways to care for their aesthetic appearance beyond topical interventions. Nutrition- and nutricosmetic-focused products complement topical regimens and work on a systemic level, which can also provide whole-body health benefits beyond skin, hair, or nails.”

On a very basic level, it’s understood that our health impacts our appearance; therefore, it’s not difficult for consumers to accept that nutritional intervention can have a positive impact on skin, hair, and nail health. In clinical settings, dietary intervention has been a valuable way to treat symptoms of skin conditions.

 For example, a survey of 270 psoriasis patients found that over half tried between one to four dietary interventions or supplements to treat symptoms. These included diets such as the ketogenic diet or supplements like probiotics. Also, according to the survey, 30% of respondents attempted to lose weight, with one-third of those trying to lose weight experiencing a positive impact on their psoriasis severity. Of those who endorsed weight-loss interventions, 50% attributed improvements in psoriasis to the ketogenic diet.

In the dietary supplements realm, vitamin D was tried by 32% of survey respondents, 25% tried oral fish oil, and 21% tried probiotics. Of those who took probiotics, 29% reported improvements in psoriasis symptoms, while 28% and 26% of patients taking vitamin D and fish oil, respectively, reported improvements in symptoms. While dietary supplements cannot claim to prevent, treat, or cure diseases, the survey demonstrates how dietary supplements may positively impact both physical wellbeing and appearance.

At this point, consumers are no strangers to hair-, skin-, and nail-support ingredients such as collagen and biotin. In fact, those ingredients are still seeing great growth. Collagen, for example, saw 61% sales growth in the hair, skin, and nail category of the mainstream multioutlet channel, according to SPINS, during the 52 weeks ending October 31, 2021. Demand remains high for ingredients that tackle more urgent concerns such as hair and skin health, because those have a more immediate impact on our appearance. However, the category is getting more sophisticated with products that tackle long-term aging and the health of the microbiome.

A relatively recent entrant in the skin microbiome space is For The Biome, which was cofounded by Paul and Barbi Schulick, who are best known for cofounding the New Chapter dietary supplement brand, which was subsequently acquired by Procter & Gamble. In an interview with 

, Paul Schulick explained that while many topical body care products tout themselves as being microbiome friendly—meaning they do not disrupt the skin’s microbiome—nutricosmetic brands like For The Biome encourage microbiome diversity from the inside out.

Probiotics and other microbiome products are already immensely popular, so it’s only natural that they become adopted by the nutricosmetics space. The concept of the skin microbiome can be expected to evolve further as probiotic manufacturers do more research and development and brand owners adopt these ingredients.

“Microbiome science has exploded over the last few years. And although it is a complicated science to understand, the ‘skin minimalist’ movement, along with a growing number of education platforms and brands, have helped move this category more into mainstream,” says Simpson. “The concept is the opposite, too, of what we have been taught previously from a skincare perspective. ‘Squeaky clean’ today is a completely different concept over what it meant even 10 years ago. This market will continue to evolve as the science becomes streamlined in a way that the consumer can fully relate to.”

One of the biggest challenges with introducing innovative products and product categories is educating consumers about the value of these products. This is particularly true if the benefits they offer are a bit abstract.

“When supplementing for hair and nails, visible improvements are noticed more quickly over, say, ‘antioxidant formulation to combat skin aging.’ So different claims and formulations need different marketing and proof-of-concept to peak consumer interest and brand loyalty,” explains Simpson. “Also, when topical products are applied, there is often an immediate result or effect. Nutricosmetics work on a whole different physiological mechanism and thus should not be marketed [the same way] as topical regimens. They certainly complement topical products, but the two are completely different in the way they work.”

It may therefore be beneficial to manage expectations, because immediately tangible results are not always possible. On other hand, offering consumers more specialized support is an important way to set your brand apart, says Simpson. Again, the key is clear communication.

“Although multifunctional products are on the upswing for consumer demand, my biggest recommendation is to identify your unique point of difference, how the product works, and never rush through the education and marketing of the product. It will only get lost in the noise,” Simpson advises.

Ultimately, good science, sound marketing, and consumer education are key when it comes to broadening the scope of nutricosmetic products. New concepts need time to take hold, but consumers are open to trying new things if they can understand clearly why they should be taking a product. For example, what 

 the benefits of a healthy skin microbiome? Communicate these benefits, but don’t make irresponsible claims. And while consumers may be willing to try innovative new products, they won’t continue to use the products unless they work.

Herein lies a potential trap for manufacturers of finished products: Because of the popularity of alternative dosage formats such as gummies, or functional foods and beverages, there is a desire to also produce more of these products to meet the demand. However, says Simpson, do so only if there is no loss in product efficacy.

“The downside is that certain actives are best manufactured in certain forms for optimal bioavailability and formulation stability. So, although a unique product format hits the market, the ingredients may not work as effectively if in other formats,” Simpson points out. “This is where I see product efficacy losing the battle with marketing trends. Always something to be wary of.”

The nutricosmetics space appeals to people’s vanity. In fact, vanity is often what motivates people to eat healthily and work out. When you put it that way, the opportunity for the nutricosmetic space is huge. Emerging trends within the category, such as skin microbiome support, offer important points of differentiation, but benefits should be well researched and communicated so that consumers get what they pay for and these new trends don’t die on the vine.

Patients share experience with dietary intervention, supplement use

, Psoriasis Supplement, vol. 42, no. 2 (2021)

Microbiome-friendly formulations are the future of skincare, says For The Biome cofounder Paul Schulick

Consumers don’t just want clean-label beauty products. They want clean-label products that really work.

Starting in 2017, supplements industry giant NOW began purchasing dietary supplements from various, often lesser known, brands sold on Amazon.com and 

. Finding many products not meeting their label claims, NOW alerted Amazon.com and FDA about these deficiencies. At this point, NOW has tested products in many product categories, including 

and quercetin. Recently, the company turned its attention back to CoQ10 and quercetin, retesting some supplements previously tested and testing some new ones, and found that there was “no improvement in policing quality.”

The company reexamined eight CoQ10 products it tested and found to be of low potency back in 2020. According to the company’s latest press release, after retesting those products in April 2022, NOW “found the same serious problems remain for seven out of eight brands tested,” with seven out of eight brands containing less than 30% of the potency claimed. Not only that, but many products were mislabeled by “misrepresenting potencies through deceptive labeling tricks.”

For instance, says NOW, “Clear Formulas, aSquared, Foxy Doc, and Healthy Way brands all mislabel their product as ‘400 mg / 6%’ potency. This is deceptive when the front panel says ‘400 mg’ potency and the Amazon title says ‘CoQ10 400 mg Max Strength.’ The customer gets less than 24 mg CoQ10 per capsule,” because the product only contains a percentage of the full potency. But by reading the label, the consumer might assume that the full 400-mg potency is in the product.

NOW purchased and tested three samples per product using HPLC. Testing was performed not only internally at NOW’s labs but also by third-party lab Eurofins.

NOW adds that “It is apparent by looking at lot numbers and bottle types that the same manufacturer is supplying multiple brands with the same fraudulent products…”

NOW also recently tested a large group of quercetin supplements purchased on Amazon.com. According to the company, quercetin demand grew during the COVID-19 pandemic, causing raw material costs to increase. Higher ingredient prices lead to higher risk of low-potency products, even though labels might claim the product is high potency.

The company found that 20 out of 24 quercetin product brands tested were below 90% label potency, with 14 out of 24 actually containing less than 50% of the labeled potency. It also found the same labeling deception happening with the quercetin products, with some companies labeling their products as containing “18% potency” but inferring the consumer gets more quercetin than that.

Another problem detected involved quercetin dihydrate. As NOW’s press release explains, “Quercetin dihydrate 95% is the raw ingredient used in supplements, and some brands claim ‘400 mg quercetin’ while others may claim ‘420 mg quercetin dihydrate’ and the potency is identical. Some brands label as ‘quercetin dihydrate’ to show a higher label claim, although this is not normal. Quality brands such as NOW input at least 10% overage quercetin dihydrate in order to compensate for quercetin dihydrate being 95% quercetin.”

Another problem NOW detected in its testing of both ingredients is companies claiming that their capsules are vegan or vegetarian when they actually contain gelatin.

NOW said it again plans to send its findings to Amazon, FDA, and the FTC, hoping that some progress can be made in addressing these problems. Despite NOW’s previous attempts to warn the retailer and regulators, it appears, upon retesting, that many problematic products are still being sold on Amazon.

“NOW has reported these findings to Amazon directly, as we did previously, but the products continue to be sold and often as a ‘sponsored’ (paid marketing) featured products,” said Dan Richard, vice president of global sales and marketing for NOW.

Recently, the company turned its attention back to CoQ10 and quercetin, retesting some supplements previously tested and testing some new ones, and found that there was “no improvement in policing quality.”

NOW again tests CoQ10 and quercetin products bought on Amazon.com and finds no improvement in quality 

Cargill (Minneapolis) plans to double its production of tapioca syrup by expanding processing capabilities at its sweeteners plant in Cikande, Indonesia. The company says there is growing demand for its organic, non-GMO tapioca syrup, which can be used in foods like ice cream, snack bars, and confectioneries.

The company has invested $2.4 million to upgrade the plant’s filling stations, blending and storage tanks, and warehouses. Its goal is to produce 12,000 MT annually of tapioca syrup by 2024. The Cikande plant is also located near major tapioca-growing regions in Asia.

Tapioca syrup is sourced from the cassava plant and is seen as label friendly by consumers, the company adds.

Tapioca syrup can be used in food products such as ice cream, snack bars, and confectioneries.

Cargill doubling tapioca syrup production to meet demand

Clasado Biosciences (Reading, UK) has announced that the European Food Safety Authority (EFSA) has given a positive opinion on the extension of the use of galactooligosaccharises (GOS) as a novel food in food for special medical purposes (‘FSMP’) in the EU. This was accomplished in collaboration with Clasada’s partner GLNP Life Sciences BV (‘GNLP’), a specialist FSMP producer in Europe.

Following a request from the European Commission, EFSA reviewed the safety of prebiotic GOS, specifically Bimuno GOS as a novel food to be used in FSMPs intended for the dietary management of impaired gastrointestinal issues in hospitalized patients. The 

 was published on March 30, 2022. The use of Bimuno GOS is still pending approval from the European Commission.

“With the EFSA positive opinion on the use of GOS in FSMP applications, this presents the opportunity to embark on a brand-new and promising journey for the business. The opinion published in the EFSA Journal centers around indirectly tackling malnutrition in hospitalized patients where gut microbiome dysbiosis is a common factor; fiber content is key and as a prebiotic substrate, Bimuno GOS certainly fits the bill,” said Per Rehné, CEO of Clasado Bioscience, in a press release. “Following an eventual authorization from the Commission, we can hopefully affect more positive change across the spectrum of health and wellbeing. This positive opinion is a fantastic step forward, whereby we appreciate GLNP’s efforts in helping to unlock Bimuno GOS potential in FSMP’s.”

“Using prebiotics within the FSMP category represents an exciting opportunity where prebiotics can potentially play a key role within the European market,” added Gijs Roozendaal, general manager at GLNP Food Sciences BV. “Working with a leading prebiotic ingredient developer like Clasado, that focuses on strong scientific backing, is an essential step in accelerating our understanding of gut-mediated health, and crucially, turning that knowledge into action and solutions that make a difference.”

Clasado Biosciences has announced that the European Food Safety Authority (EFSA) has given a positive opinion on the extension of the use of galactooligosaccharises (GOS) as a novel food in food for special medical purposes (‘FSMP’) in the EU. 

Featured Content

Consumers want clean-label products that really work

Immune health: New, novel ingredients are on the scene